Abstract:The utilization of chicken oviductal epithelial cells (OECs) as a bioreactor to produce therapeutic proteins has shown promise, but the time taken to obtain transgenic offspring impedes efficient validation of protein production. To overcome this barrier, we focused on the immortalization of chicken OECs (cOECs) using retroviral vector-mediated c-MYC oncogene expression to establish an in vitro pre-validation system for chicken bioreactors. The resulting immortalized cOECs exhibited sustained proliferation, maintained a normal diploid chicken karyotype, and expressed key oviduct-specific genes (OVA, OVM, LYZ, AVD, and ESR1). Notably, hormonal administration of diethylstilbestrol (DES) or progesterone (P4) upregulated oviduct-specific genes in these cells. To enhance the utility of these immortalized cOECs as an in vitro validation system for chicken bioreactors, clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) technology was employed to knock-in (KI) an enhanced green fluorescence protein (EGFP) gene at the ovalbumin (OVA) locus. The resulting OVA EGFP KI immortalized cOECs secreted both EGFP and OVA proteins into the culture medium, with secretion enhanced under DES treatment. This successful integration of an exogenous gene into cOECs enhances their potential as a versatile in vitro validation system for chicken bioreactors. The established immortalized cOECs overcome previous challenges associated with long-term culture and maintenance, providing a reliable platform for efficient protein production validation. This study presents a comprehensive characterization of the immortalized cOECs, addressing critical limitations associated with in vivo systems and laying a foundation for the development of a streamlined and effective chicken bioreactor model.

Experimental studies from shake flasks to 3 L stirred tank bioreactor of nutrients and oxygen supply conditions to improve the growth of the avian cell line DuckCelt®-T17

Oxygen Uptake Rate analysis to evaluate the impact of hydrodynamic stress on the growth of the avian cell line DuckCelt®-T17

The Avian EB66(R) Cell Line, Application to Vaccines, and Therapeutic Protein Production

Optimization of Culture Media and Feeding Strategy for High Titer Production of an Adenoviral Vector in HEK 293 Fed-Batch Culture

Process Optimization for the Rapid Production of Adenoviral Vectors for Clinical Trials in a Disposable Bioreactor System.

A Novel Scale-Up Strategy for Cultivation of BHK-21 Cells Based on Similar Hydrodynamic Environments in the Bioreactors.

A Study on Scale-up Process for Microcarrier Cultue of MDCK Cells Using Low Serum Medium

Semi-perfusion Cultures of Suspension MDCK Cells Enable High Cell Concentrations and Efficient Influenza A Virus Production.

Large-scale microcarrier culture of HEK293T cells and Vero cells in single-use bioreactors

From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process development

High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system

Highly Efficient Production of an Influenza H9N2 Vaccine Using MDCK Suspension Cells

Impact of hydromechanical stress on CHO cells' metabolism and productivity: Insights from shake flask cultivations with online monitoring of the respiration activity

Medium optimization based on comparative metabolomic analysis of chicken embryo fibroblast DF-1 cells

Fed‐batch strategies for intensified rVSV vector production in high cell density cultures of suspension HEK293 cells

Computational fluid dynamics based digital twins of fixed bed bioreactors validate scaling principles for recombinant adeno-associated virus gene therapy manufacturing

An in vitro validation system for chicken bioreactors using immortalized chicken oviductal epithelial cells

Exploring nutrient supplementation and bioprocess optimization to improve the production of lentiviral vectors in serum‐free medium suspension cultures

Development, Characterization and Optimization of a New Suspension Chicken-Induced Pluripotent Cell Line for the Production of Newcastle Disease Vaccine.

Mass Cultivation of Marine Fish Chinook Salmon Embryo Cells in Bioreactor with Low-Serum Medium

Development of Scale up for the Production of Influenza Vaccine Based on MDCK Suspension Cells